Chronix Biomedical today announced placard of a study that supports the utility of its serum DNA blood tests for the early and close find of breast cancer. The Chronix tests detect the circulating DNA that is released into the blood stream by damaged and dying cells. A growing body of publications from Chronix and other researchers shows that this circulating DNA can be identified and analyzed to provide a diagnostic window into ongoing changes in the genome customer's broker person with special diseases"changes that can be used to diagnose disease processes at an early stage and to track responses to treatment.

More: - Continued here